We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
TASE analysis project launched in 2016 to increase investor knowledge of TASE's listing technology and life science companies and the company's operating market
US drug maker Mylan has announced its intention to withdraw from the Tel Aviv Stock Exchange (TASE), ending its involvement for the first time since it entered it in November 2015.